• The global Parkinson's Disease Therapeutics market size was estimated at USD 2415 million in 2023 and is projected to reach USD 4080.09 million by 2032, exhibiting a CAGR of 6.00% during the forecast period.
• North America Parkinson's Disease Therapeutics market size was estimated at USD 695.67 million in 2023, at a CAGR of 5.14% during the forecast period of 2024 through 2032.
Email: help@24marketreports.com
• Parkinson's disease (PD), or simply Parkinson's, is a chronic degenerative disorder of the central nervous system that affects both the motor system and non-motor systems. The symptoms usually emerge slowly, and as the disease worsens, non-motor symptoms become more common. Early symptoms are tremor, rigidity, slowness of movement, and difficulty with walking. Problems may also arise with cognition, behaviour, sleep, and sensory systems. Parkinson's disease dementia becomes common in advanced stages of the disease.
• Parkinsons Disease Therapeutics Market provides a deep insight into the global Parkinson's Disease Therapeutics market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
Email: help@24marketreports.com
+1(917)-997-2424
• Under 40 Years Old
• 40-65 Years Old
• Above 65 Years Old
